BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.040
-0.020 (-1.89%)
At close: May 30, 2025, 4:00 PM
0.9900
-0.0500 (-4.81%)
After-hours: May 30, 2025, 5:32 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $19.19 million as of May 30, 2025. Its market cap has decreased by -0.05% in one year.
Market Cap
19.19M
Enterprise Value
-3.60M
1-Year Change
-0.05%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $19.19M, a decrease of -63.10%. That is a compound annual growth rate of -19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 19.70M | -44.51% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |